Loading data for DNA — first visit, this takes a few seconds.
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA
· 实时价格 · USD
6.79
+0.00 (0.00%)
收盘价： Sep 10, 2026, 3:17 PM
股价、关键数字和最新消息，都在这一页。
Ginkgo Bioworks Holdings, Inc.（DNA）股价、分析与数据
暂无数据
| 买价 | 6.78 |
| 市值 | 458M |
| 营收（TTM） | 132M |
| 净利润（TTM） | -310M |
| 1.77 | |
| -5.33 | |
| n/a | |
| -2.34 | |
| 市净率（TTM） | 1.03 |
| 市销率（TTM） | 3.46 |
| 财报日期 | Nov 5, 2026 |
| 卖价 | 6.8 |
| 成交量 | 149,818 |
| 20日均量 | 1,108,103 |
| 开盘价 | 6.72 |
| 前收盘价 | 6.79 |
| 日内区间 | 6.59 - 6.83 |
| 52周区间 | 5.37 - 17.58 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 DNA
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automat...
公司完整简介财报意外
Ginkgo Bioworks s 已于 Aug 5, 2026 发布季度财报：
- 营收为 $20.16M 低于预期 $0, ， -48.49% 同比下滑.
- 每股收益为 -0.73 低于预期 -0.03, ， 33.64% 同比增长.
第 1 页，共 2 页